FI915163A - Nya 2-sackarinylmetylarylkarboxylater anvaendbara som inhibitorer foer proteolytiskt enzym och kompositioner och metoder foer deras anvaendning. - Google Patents
Nya 2-sackarinylmetylarylkarboxylater anvaendbara som inhibitorer foer proteolytiskt enzym och kompositioner och metoder foer deras anvaendning. Download PDFInfo
- Publication number
- FI915163A FI915163A FI915163A FI915163A FI915163A FI 915163 A FI915163 A FI 915163A FI 915163 A FI915163 A FI 915163A FI 915163 A FI915163 A FI 915163A FI 915163 A FI915163 A FI 915163A
- Authority
- FI
- Finland
- Prior art keywords
- och
- foer
- sackarinylmetylarylkarboxylater
- proteolytiskt
- metoder
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C07F9/6539—Five-membered rings
- C07F9/6541—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI944968A FI944968A (fi) | 1990-11-01 | 1994-10-21 | Menetelmä sakkariinijohdannaisten valmistamiseksi |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60806890A | 1990-11-01 | 1990-11-01 | |
| US60806890 | 1990-11-01 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI915163A0 FI915163A0 (fi) | 1991-11-01 |
| FI915163A true FI915163A (fi) | 1992-05-02 |
| FI103112B FI103112B (fi) | 1999-04-30 |
| FI103112B1 FI103112B1 (fi) | 1999-04-30 |
Family
ID=24434891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI915163A FI103112B1 (fi) | 1990-11-01 | 1991-11-01 | Menetelmä proteolyyttisen entsyymin inhibiittoreina käyttökelpoisten 2-sakkarinyylimetyyliaryylikarboksylaattien valmistamiseksi |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0483928A1 (fi) |
| JP (1) | JPH04273866A (fi) |
| KR (1) | KR920009807A (fi) |
| AU (1) | AU642537B2 (fi) |
| CA (1) | CA2054653A1 (fi) |
| FI (1) | FI103112B1 (fi) |
| HU (2) | HUT63399A (fi) |
| IE (1) | IE913827A1 (fi) |
| IL (1) | IL99913A (fi) |
| MX (1) | MX9101861A (fi) |
| MY (1) | MY131053A (fi) |
| NO (1) | NO300373B1 (fi) |
| NZ (1) | NZ240444A (fi) |
| PT (1) | PT99411B (fi) |
| RU (1) | RU2114843C1 (fi) |
| SG (1) | SG69977A1 (fi) |
| TW (1) | TW221294B (fi) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2110414T3 (es) * | 1989-05-04 | 1998-02-16 | Sanofi Sa | Derivados de sacarina utiles como inhibidores de enzimas proteoliticas y su preparacion. |
| US5306818A (en) * | 1990-11-01 | 1994-04-26 | Sterling Winthrop Inc. | Tetrahydro 2-saccharinylmerthyl aryl carboxylates |
| US5512589A (en) * | 1990-11-01 | 1996-04-30 | Sterling Winthrop Inc. | 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| AU656027B2 (en) * | 1991-11-15 | 1995-01-19 | Sanofi | Saccharin derivative proteolytic enzime inhibitors |
| AU668694B2 (en) * | 1991-12-19 | 1996-05-16 | Sanofi-Synthelabo | Saccharin derivative proteolytic enzyme inhibitors |
| US5378720A (en) * | 1991-12-19 | 1995-01-03 | Sterling Winthrop Inc. | Saccharin derivative proteolytic enzyme inhibitors |
| US5296496A (en) * | 1991-12-27 | 1994-03-22 | Sterling Winthrop Inc. | 2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| US5187173A (en) * | 1991-12-27 | 1993-02-16 | Sterling Winthrop Inc. | 2-saccharinylmethyl and 4,5,6,7-tetrahydro-2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| AU653279B2 (en) * | 1991-12-30 | 1994-09-22 | Sanofi | Novel 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| TW226016B (fi) * | 1991-12-30 | 1994-07-01 | Sterling Winthrop Inc | |
| US5684195A (en) * | 1994-07-14 | 1997-11-04 | G. D. Searle & Co. | Method of preparing sulfmonamides from sulfones |
| DE4427996A1 (de) * | 1994-08-08 | 1996-02-15 | Basf Ag | Verfahren zur Herstellung von Saccharincarbonsäuren und -carbonsäureestern |
| DE19533643A1 (de) * | 1995-09-12 | 1997-03-13 | Nycomed Arzneimittel Gmbh | Neue cyclische Derivate von Benzolsulfonamiden |
| JP6239458B2 (ja) * | 2014-07-22 | 2017-11-29 | 日本曹達株式会社 | ２−（ベンジルスルフィニル）−１−シクロアルケン−１−カルボン酸エステルの製造方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4276298A (en) * | 1978-03-24 | 1981-06-30 | Merck & Co., Inc. | 2-Aryl-1,2-benzisothiazolinone-1,1-dioxides and their use as selective protease inhibitors |
| DE3617976A1 (de) * | 1986-05-28 | 1988-01-14 | Alter Sa | 1,4-dihydropyridin, verfahren zu dessen herstellung und dessen verwendung in antithrombotischen medikamenten |
| ES2110414T3 (es) * | 1989-05-04 | 1998-02-16 | Sanofi Sa | Derivados de sacarina utiles como inhibidores de enzimas proteoliticas y su preparacion. |
-
1991
- 1991-10-24 AU AU86083/91A patent/AU642537B2/en not_active Ceased
- 1991-10-30 MX MX9101861A patent/MX9101861A/es not_active IP Right Cessation
- 1991-10-30 EP EP91202809A patent/EP0483928A1/en not_active Withdrawn
- 1991-10-30 SG SG1996007579A patent/SG69977A1/en unknown
- 1991-10-31 HU HU913430A patent/HUT63399A/hu unknown
- 1991-10-31 IL IL9991391A patent/IL99913A/en not_active IP Right Cessation
- 1991-10-31 CA CA002054653A patent/CA2054653A1/en not_active Abandoned
- 1991-10-31 PT PT99411A patent/PT99411B/pt not_active IP Right Cessation
- 1991-11-01 RU SU5010338A patent/RU2114843C1/ru active
- 1991-11-01 KR KR1019910019381A patent/KR920009807A/ko not_active Application Discontinuation
- 1991-11-01 JP JP3288080A patent/JPH04273866A/ja active Pending
- 1991-11-01 NO NO914288A patent/NO300373B1/no unknown
- 1991-11-01 NZ NZ240444A patent/NZ240444A/en unknown
- 1991-11-01 FI FI915163A patent/FI103112B1/fi active
- 1991-11-01 IE IE382791A patent/IE913827A1/en not_active Application Discontinuation
- 1991-11-01 MY MYPI91002030A patent/MY131053A/en unknown
- 1991-11-04 TW TW080108649A patent/TW221294B/zh active
-
1995
- 1995-06-29 HU HU95P/P00542P patent/HU211929A9/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MY131053A (en) | 2007-07-31 |
| NO914288D0 (no) | 1991-11-01 |
| FI103112B (fi) | 1999-04-30 |
| EP0483928A1 (en) | 1992-05-06 |
| IE913827A1 (en) | 1992-05-22 |
| NZ240444A (en) | 1994-06-27 |
| PT99411A (pt) | 1992-10-30 |
| FI915163A0 (fi) | 1991-11-01 |
| IL99913A (en) | 1996-11-14 |
| HUT63399A (en) | 1993-08-30 |
| IL99913A0 (en) | 1992-08-18 |
| HU913430D0 (en) | 1992-01-28 |
| AU8608391A (en) | 1992-05-07 |
| NO914288L (no) | 1992-05-04 |
| KR920009807A (ko) | 1992-06-25 |
| HU211929A9 (en) | 1996-01-29 |
| FI103112B1 (fi) | 1999-04-30 |
| JPH04273866A (ja) | 1992-09-30 |
| TW221294B (fi) | 1994-02-21 |
| NO300373B1 (no) | 1997-05-20 |
| PT99411B (pt) | 1999-04-30 |
| RU2114843C1 (ru) | 1998-07-10 |
| SG69977A1 (en) | 2000-01-25 |
| MX9101861A (es) | 1992-07-08 |
| CA2054653A1 (en) | 1992-05-02 |
| AU642537B2 (en) | 1993-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI893105A0 (fi) | Tryckkapsel foer spraybehaollare och spraybehaollare som utnyttjar en saodan kapsel. | |
| FI903929A0 (fi) | Proteiner som induserar immunologisk effektorcellaktivation och kemattraktion. | |
| FI914319A (fi) | Nya karbocykliska adenosinanaloger anvaendbara som immunosupressanter. | |
| FI906334A (fi) | Nya e-vitaminderivat och foerfarande foer framstaellning daerav. | |
| FI923756A0 (fi) | Polyolefinkompositioner som omfattar glycerolmonoestrar av c20-24-fettsyror och daerav framstaellda skumprodukter. | |
| FI915400A (fi) | Nya tricykliska foereningar. | |
| FI915163A (fi) | Nya 2-sackarinylmetylarylkarboxylater anvaendbara som inhibitorer foer proteolytiskt enzym och kompositioner och metoder foer deras anvaendning. | |
| FI872355A0 (fi) | Smoerjmedel och nya polyfluorerade foereningar som kan anvaendas som tillsatsaemnen. | |
| FI923762A0 (fi) | Nya heparinderivat. | |
| FI913407A0 (fi) | Nya purinderivat. | |
| FI914071A0 (fi) | Nya hetrazepinoida amider. | |
| FI890285A0 (fi) | Nya aminosyraglycerider, foerfaranden foer deras framstaellning, dessa innehaollande laekemedel och deras anvaendning. | |
| FI913138A (fi) | Foerfarande foer framstaellning av b -laktamer som innehaoller aminotiazol(iminooxiaettiksyra) aettiksyrasidokedjor och mellanprodukter daerav. | |
| FI915435A0 (fi) | Nya leukotrien-b4-derivater, foerfarande foer deras framstaellning och deras anvaendning som laekemedel. | |
| FI915609A (fi) | Foerfarande och anordning foer styrning av en m-pulsvaexelriktaranordning som bestaor av en mastervaexelriktare och aotminstone en slavvaexelriktare. | |
| FI892897A0 (fi) | Nya kondenserade diazepinoner, foerfarande foer deras framstaellning och laekemedel som innehaoller dessa foereningar. | |
| FI911351A0 (fi) | Nya 8-sulfamylmetylen-2 -aminotetraliner. | |
| FI912317A0 (fi) | Nya tricykliska foereningar. | |
| FI914309A0 (fi) | Nya aminosyraderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutisk blandning. | |
| FI845125L (fi) | Nya 1,4-naftokinonderivat, foerfarande foer deras framstaellning och deras anvaendning som laekemedel. | |
| FI911508A (fi) | Nya isokromanderivat. | |
| FI890380A0 (fi) | Nya kondenserande diazepinoner, foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel. | |
| FI921691A0 (fi) | Nya adenosinderivat, deras framstaellning och anvaendning. | |
| FI892896A (fi) | Nya kondenserade diazepinoner, foerfarande foer deras framstaellning och laekemedel som innehaoller dessa foereningar. | |
| FI895899A0 (fi) | Nya trombolytiska proteiner, foerfarande foer deras framstaellning och dessa som aktivaemne innehaollande laekemedel. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or assigment of application |
Owner name: SANOFI |